Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Striatal 18 F‐6‐fluorodopa (FD) uptake constants were measured by positron emission tomography in (1) normal cynomolgus monkeys and (2) a series of cynomolgus and rhesus monkeys that had received intracarotid infusions of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). After the animals were killed, the number and average size of dopaminergic neurons in the substantia nigra pars compacta were measured. Striatal levels of dopamine and its metabolites, and the striatal activities of the dopaminergic synthetic enzymes, were also determined. The striatal FD uptake constants showed highly significant positive correlations with both number and size of dopaminergic neurons, indicating atrophy of surviving neurons in MPTP‐treated animals. The uptake constants also showed significant positive correlations with striatal levels of dopamine, total catecholamines, and the activities of the synthetic enzymes. Both histochemical and biochemical data on tyrosine hydroxylase suggested some contralateral enzyme loss in these MPTP‐treated monkeys, as well as decreased enzyme activity in surviving neurons on the lesioned side. However, residual enzyme activities were apparently not rate limiting to striatal FD uptake. It is concluded that PET‐FD measurements by positron emission tomography provide a good index of the integrity of the nigrostriatal pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
Neocortical cell counts in normal human adult aging
Terry, R. D., DeTeresa, R., & Hansen, L. A. (1987) · Annals of Neurology · doi:10.1002/ana.410210603 · Cited by 685
Dopamine visualized in the basal ganglia of living man
Garnett, E. S., Firnau, G., & Nahmias, C. (1983) · Nature · doi:10.1038/305137a0 · Cited by 644
Brooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., Bannister, R., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280412 · Cited by 626
Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Björklund, A., Lindvall, O., & Langston, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272203 · Cited by 488
Self-citationTago, H., Kimura, H., & Maeda, T. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.11.2430009 · Cited by 426
Leenders, K. L., Palmer, A. J., Quinn, N., Clark, J. C., Firnau, G., Garnett, E. S., Nahmias, C., Jones, T., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.8.853 · Cited by 354
Cited by
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Lee, C. S., Samii, A., Sossi, V., Ruth, T. J., Schulzer, M., Holden, J. E., Wudel, J., Pal, P. K., De La Fuente-Fernandez, R., Calne, D. B., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<493::aid-ana13>3.0.co;2-4 · Cited by 580
Self-citationFetal nigral transplantation as a therapy for Parkinson's disease
Olanow, C. W., Kordower, J. H., & Freeman, T. B. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80038-5 · Cited by 416
The role of radiotracer imaging in Parkinson disease
Ravina, B., Eidelberg, D., Ahlskog, J. E., Albin, R. L., Brooks, D. J., Carbon, M., Dhawan, V., Feigin, A., Fahn, S., Guttman, M., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000149403.14458.7f · Cited by 374
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Vingerhoets, F. J. G., Schulzer, M., Calne, D. B., & Snow, B. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410111 · Cited by 359
Self-citationWelding-related parkinsonism: Clinical features, treatment, and pathophysiology
Sadak, A. H., & Schulz, P. E. (2001) · Neurology · doi:10.1212/wnl.57.9.1738-a · Cited by 299
Adams, J. R., van Netten, H., Schulzer, M., Mak, E., Mckenzie, J., Strongosky, A., Sossi, V., Ruth, T. J., Lee, C. S., Farrer, M., et al. (2005) · Brain · doi:10.1093/brain/awh607 · Cited by 262
Self-citationVingerhoets, F. J. G., Snow, B. J., Lee, C. S., Schulzer, M., Mak, E., & Calne, D. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360512 · Cited by 218
Self-citationNonhuman Primate Models of Parkinson's Disease
Emborg, M. E. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.339 · Cited by 190
Collier, T. J., Lipton, J., Daley, B. F., Palfi, S., Chu, Y., Sortwell, C., Bakay, R. A. E., Sladek, J. R., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.013 · Cited by 162
Progression of monoaminergic dysfunction in parkinson's disease: a longitudinal 18f-dopa pet study
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L., & Brooks, D. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.012 · Cited by 145
“…in PD. Striatal uptake of 18 Fdopa , which reflects aromatic amino acid decarboxylase activity (AADC), correlates well with nigral cell counts and striatal tyrosine hydroxylase activity in both human cases and in primates with MPTP induced parkinsonism (Snow et al, 1993, Pate et al, 1993).”
BackgroundBlinded positron emission tomography study of dopamine cell implantation for Parkinson's disease
Nakamura, T., Dhawan, V., Chaly, T., Fukuda, M., Ma, Y., Breeze, R., Greene, P., Fahn, S., Freed, C., & Eidelberg, D. (2001) · Annals of Neurology · doi:10.1002/ana.1075 · Cited by 67
Metadata
- Authors
- Pate, B. D., Kawamata, T., Yamada, T., McGeer, E. G., Hewitt, K. A., Snow, B. J., Ruth, T. J., & Calne, D. B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-09
- Volume
- 34
- Issue
- 3
- Pages
- 331-338
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2083998198
- Cited by
- 168
- References
- 30
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.